Viewpoint: Here’s why the European Parliament’s plan for loosening crop biotech editing regulations is two steps forward, three steps backward

european union gff bd e

Many welcomed the European Parliament’s adoption, with a narrow majority of 307 votes for, 263 against and 41 abstentions, of its position on the “proposal for a regulation of the European Parliament and of the Council concerning plants obtained by means of certain new genomic techniques and the food and feed derived therefrom, and amending Regulation (EU) 2017/625.”

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Conceptually, NTG-1 products are indistinguishable from what can be obtained by “conventional” selection methods (they are “equivalent”). Category 2 NGTs are everything else and their regulations are essentially unchanged (their products are three-card, like “GMOs”, on European soil, but not necessarily on import).

For products from NTG-1, the proposal provided for a lighter authorization regime consisting essentially of a declaration, followed by verification of the NGT-1 status and entry of this status in a register. The ENVI commission proposed adding labeling to seeds and plants, which does not change much, except for the information of farmers.

But the European Parliament adopted… an amendment… which imposes labeling of products, defined very extensively. Naturally, this is of good value, [when it comes to] nutritional or other advantages for consumers. For agronomic improvements (apart from tolerance to a herbicide, which is necessarily reviled) and technological improvements, this will be holy bread for the very influential and very trendy anti-GMO, anti-capitalist, etc. microcosm. A dream support for anxiety!

[Editor’s Note: This article has been translated from French and edited for clarity.]

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1
The FDA couldn’t find a vaccine safety crisis, so it buried its own research
Screenshot-2026-04-22-at-12.21.32-PM
Viewpoint: Why the retracted Monsanto glyphosate study doesn’t change the science—the world’s most popular herbicide is safe 
ChatGPT-Image-May-7-2026-12_32_36-PM
Viewpoint: The state of U.S. vaccine policy? Dismal nationally, but some states are stepping up.
placebo
Viewpoint — Alternative medicine and the placebo effect: Selling a reassuring illusion of health
_20250221_nib_rfk_trump
Viewpoint: 'Crisis of public trust': Autism support community shocked RFK continues to peddle false claims about the danger of vaccines
ChatGPT-Image-May-18-2026-01_45_05-PM-2
Newest hantavirus conspiracy: Online disinformation turns outbreak into latest ivermectin grift
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
the magic of mRNA
Viewpoint: Anti-vax fake ‘turbo cancer’ claims threaten cancer treatment breakthroughs
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
ChatGPT-Image-May-18-2026-12_06_18-PM-2
Defying death: The immortality movement goes mainstream
Defense_Secretary_Ash_Carter_tours_the_Microsoft_Cybercrime_Center_in_Seattle_March_3_2016
How criminals are using AI to target social media users and steal their money and confidential data
ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claim? The evidence says mostly the opposite
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.